In addition, B7-H4 expression in human gastric cancer and esophageal cancer have also been suggested to be significantly associated with cancer progression, reduced tumor immuno-surveillance as well as worse patient outcomes, and thus the role of B7-H4 molecule as a novel prognostic predictor for these malignancies has been predicted [4, 14]. Here, VTCN1 is linked to gastric cancer.